Evaluation of the cost-effectiveness of the high-chloride vs. low-chloride crystalloid fluids in hospitalized patients from the us third-party provider perspective

被引：0

作者：

D Makhija

S Laplante

I Beer

C Schermer

L Perrault

机构：

[1] Baxter Healthcare Corporation,

[2] Former Baxter Healthcare Corporation Employee,undefined

[3] International Market Access Consulting,undefined

来源：

关键词：

Intensive Care Unit; Chronic Kidney Disease; Renal Replacement Therapy; Acute Kidney Injury; Fluid Resuscitation;

D O I：

10.1186/2197-425X-3-S1-A156

中图分类号：

学科分类号：

摘要：

引用